Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metabolic Activity of Melanoma During Sorafenib and Dacarbazine
NCT00794235Phase 2Completed
- Sponsor
- University of Zurich
- Start
- Dec 2008
- Primary completion
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in melanoma, sponsored by University of Zurich. Started Dec 2008; status: completed.
02
Drugs
sorafenib
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00794235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00794235.